相关实验视频
Updated: Jan 10, 2026

06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
14.3K
在CAR-T细胞治疗中精确重编程:先进基因编辑的创新,挑战和未来方向
Zimo Jia1, Jiajin Wu1, Jiyue Zhang1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute. Beijing 100142, China.
International journal of biological sciences
|November 24, 2025
概括
像CRISPR这样的基因编辑技术正在优化化学抗原受体 (CAR) -T细胞治疗癌症. 这些进展旨在提高CAR-T细胞的疗效,持续性和安全性,扩大治疗选择.
科学领域:
- 免疫治疗是一种免疫疗法.
- 基因编辑 基因编辑
- 在瘤学瘤学.
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法在血液癌症中显示出前途.
- 卡特-T疗法面临着诸如T细胞枯竭和固体瘤中有效性有限等挑战.
- 目前的局限性阻碍了CAR-T治疗的更广泛应用和可访问性.
研究的目的:
- 审查用于CAR-T细胞治疗的基因编辑技术.
- 以突出利用基因编辑优化CAR-T细胞的进展.
- 讨论基因编辑CAR-T疗法的挑战和未来方向.
主要方法:
- 在CAR-T细胞疗法中对基因编辑工具 (CRISPR/Cas,基因编辑,原始编辑) 的当前文献进行全面审查.
- 分析提高CAR-T细胞有效性,持久性和安全性的策略.
- 检查后勤和制造方面的问题.
主要成果:
- 基因编辑为克服CAR-T疗法的局限性提供了新的方法.
- 克里斯普尔,基编辑和主要编辑可以设计CAR-T细胞以改善抗癌活性.
- 优化的CAR-T细胞显示出提高疗效和降低毒性的潜力.
结论:
- 基因编辑具有促进CAR-T细胞治疗的巨大潜力.
- 优化的CAR-T细胞可以为各种癌症提供更安全,更有效的治疗方法.
- 未来的研究应该专注于基因编辑CAR-T疗法的临床转化和更广泛的可访问性.
相关概念视频
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K
Gene Therapy
27.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.3K
Introduction to Nuclear Reprogramming
2.2K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.2K
What is Genetic Engineering?
79.6K
Overview
79.6K

